We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$1.28B
AUM Growth
+$182M
Cap. Flow
+$104M
Cap. Flow %
8.16%
Top 10 Hldgs %
33.36%
Holding
496
New
51
Increased
276
Reduced
103
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.32M
2
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$4.36M
3
AVGO icon
Broadcom
AVGO
+$3.59M
4
ORCL icon
Oracle
ORCL
+$3.13M
5
MSFT icon
Microsoft
MSFT
+$2.98M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.39M
2
FICO icon
Fair Isaac
FICO
+$859K
3
EOG icon
EOG Resources
EOG
+$838K
4
FAST icon
Fastenal
FAST
+$837K
5
CL icon
Colgate-Palmolive
CL
+$760K

Sector Composition

Rank Sector Weight
1 Technology 21.88%
2 Financials 9.45%
3 Communication Services 6.51%
4 Consumer Discretionary 5.5%
5 Industrials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWP icon
51
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$4.99M 0.39%
35,071
WMT icon
52
Walmart Inc
WMT
$890B
$4.9M 0.38%
47,567
+1,604
+3% +$160K
VONV icon
53
Vanguard Russell 1000 Value ETF
VONV
$21.2B
$4.86M 0.38%
54,358
CSCO icon
54
Cisco
CSCO
$479B
$4.76M 0.37%
69,539
+8,553
+14% +$583K
MS icon
55
Morgan Stanley
MS
$340B
$4.74M 0.37%
29,845
+364
+1% +$53.7K
AVEM icon
56
Avantis Emerging Markets Equity ETF
AVEM
$26.3B
$4.59M 0.36%
+61,049
New +$4.36M
RTX icon
57
RTX Corp
RTX
$301B
$4.53M 0.35%
27,052
+13,587
+101% +$2.11M
MDY icon
58
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$4.38M 0.34%
7,352
-25
-0.3% -$14.7K
SPDW icon
59
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.6B
$4.26M 0.33%
99,594
-3,009
-3% -$125K
WMB icon
60
Williams Companies
WMB
$86.1B
$4.26M 0.33%
67,248
+38,274
+132% +$2.25M
BX icon
61
Blackstone
BX
$110B
$4.22M 0.33%
24,707
+12,171
+97% +$2.09M
CMG icon
62
Chipotle Mexican Grill
CMG
$41.5B
$4.17M 0.33%
106,429
-787
-0.7% -$35.4K
KLAC icon
63
KLA
KLAC
$259B
$4.08M 0.32%
37,840
+3,260
+9% +$304K
PG icon
64
Procter & Gamble
PG
$339B
$4.06M 0.32%
26,421
+2,571
+11% +$402K
MA icon
65
Mastercard
MA
$493B
$4M 0.31%
7,035
+623
+10% +$358K
LMT icon
66
Lockheed Martin
LMT
$136B
$3.99M 0.31%
8,002
+2,327
+41% +$1.06M
USMV icon
67
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
$3.99M 0.31%
41,910
-530
-1% -$49.6K
XLK icon
68
State Street Technology Select Sector SPDR ETF
XLK
$124B
$3.97M 0.31%
28,180
+8
+0% +$1.06K
IAU icon
69
iShares Gold Trust
IAU
$67.5B
$3.84M 0.3%
52,816
+2,097
+4% +$137K
ETN icon
70
Eaton
ETN
$174B
$3.75M 0.29%
10,024
+24
+0.2% +$8.73K
IWS icon
71
iShares Russell Mid-Cap Value ETF
IWS
$16B
$3.67M 0.29%
26,287
-74
-0.3% -$10.1K
VWO icon
72
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$3.66M 0.29%
67,490
-268
-0.4% -$13.8K
ABT icon
73
Abbott
ABT
$187B
$3.55M 0.28%
26,530
+6,240
+31% +$819K
TJX icon
74
TJX Companies
TJX
$178B
$3.48M 0.27%
24,081
+499
+2% +$66.3K
AVUV icon
75
Avantis US Small Cap Value ETF
AVUV
$30.9B
$3.48M 0.27%
34,967
+281
+0.8% +$27.2K

Similar funds

Fidelis Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Fidelis Capital Partners held 496 positions worth $1.28B, up 17% from $1.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Fidelis Capital Partners deployed $104M of net new capital in Q3 2025, opening 51 new positions and adding to 276 existing holdings. Its largest new stake was Avantis Emerging Markets Equity ETF: 61,049 shares worth $4.59M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $1.39M trimmed.

  • Fidelis Capital Partners's largest Q3 2025 buy was Avantis Emerging Markets Equity ETF: 61,049 shares worth $4.59M.
  • Fidelis Capital Partners added most to NVIDIA in Q3 2025, an estimated $6.32M increase.
  • Fidelis Capital Partners's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.39M.
  • Fidelis Capital Partners fully exited SLB Ltd in Q3 2025, selling an estimated $453K.
  • Fidelis Capital Partners's ten largest holdings make up 33% of its $1.28B portfolio in Q3 2025.
  • Fidelis Capital Partners opened 51 new positions and closed 7 in Q3 2025.
  • Fidelis Capital Partners's portfolio value rose 17% quarter-over-quarter to $1.28B.

Based on Fidelis Capital Partners's 13F filing for Q3 2025, filed 3 Nov 2025.